Skip to Content

Pharmaceuticals, Volume 3, Issue 2

2010 February - 8 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (8)

  • Review
  • Open Access
30 Citations
17,929 Views
13 Pages

Deregulation of Interferon Signaling in Malignant Cells

  • Efstratios Katsoulidis,
  • Surinder Kaur and
  • Leonidas C. Platanias

4 February 2010

Interferons (IFNs) are a family of cytokines with potent antiproliferative, antiviral, and immunomodulatory properties. Much has been learned about IFNs and IFN-activated signaling cascades over the last 50 years. Due to their potent antitumor effect...

  • Review
  • Open Access
3 Citations
10,862 Views
14 Pages

4 February 2010

Appropriate control of blood pressure (BP) is essential for prevention of future cardiovascular events. However, BP control among treated hypertensive patients has been insufficient. Recently, the usefulness of self-measured BP at home (home BP measu...

  • Review
  • Open Access
13 Citations
12,222 Views
14 Pages

3 February 2010

The inability of most drugs to cross the blood-brain barrier and/or plasma membrane limits their use for biomedical applications in the brain. Cell Permeable Peptides (CPPs) overcome this problem and are effective in vivo, crossing the plasma membran...

  • Review
  • Open Access
12 Citations
10,993 Views
13 Pages

Renal Side Effects of Non-Steroidal Anti-Inflammatory Drugs in Neonates

  • Karel Allegaert,
  • Jan De Hoon,
  • Anne Debeer and
  • Marc Gewillig

3 February 2010

Non-steroidal anti-inflammatory drugs like ibuprofen or indomethacin are commonly prescribed drugs to induce pharmacologic closure of a patent ductus arteriosus in preterm neonates. Based on a recently published Cochrane meta-analysis, both drugs are...

  • Article
  • Open Access
1 Citations
11,254 Views
10 Pages

1 February 2010

In the attempt to discover a new polymorph of rofecoxib (Vioxx®), an unexpected product resulted. The product was characterised by chemical composition, thermal behaviour and structure and found to be 6-methylsulphonylphenanthro-[9,10-C] furan-1(3H)-...

  • Review
  • Open Access
21 Citations
14,394 Views
22 Pages

Oromucosal Administration of Interferon to Humans

  • Manfred W. Beilharz,
  • Martin J. Cummins,
  • Alayne L. Bennett and
  • Joseph M. Cummins

28 January 2010

The prevailing dogma is that, to be systemically effective, interferon-alpha (IFNα) must be administered in sufficiently high doses to yield functional blood concentrations. Such an approach to IFNa therapy has proven effective in some instances, but...

  • Review
  • Open Access
104 Citations
18,563 Views
24 Pages

Olesoxime (TRO19622): A Novel Mitochondrial-Targeted Neuroprotective Compound

  • Thierry Bordet,
  • Patrick Berna,
  • Jean-Louis Abitbol and
  • Rebecca M. Pruss

28 January 2010

Olesoxime (TRO19622) is a novel mitochondrial-targeted neuroprotective compound undergoing a pivotal clinical efficacy study in Amyotrophic Lateral Sclerosis (ALS) and also in development for Spinal Muscular Atrophy (SMA). It belongs to a new family...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Pharmaceuticals - ISSN 1424-8247